Dyskinesias were reported in 115/596 ( 19 % ) participants , 90/115 ( 78 % ) of who developed dyskinesia after levodopa was added ; 25 reported dyskinesia in the absence of levodopa ( includes patients who never received open-label levodopa , and those who reported dyskinesia before starting concomitant levodopa ) .